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ABSTRACT 
This study reports three novel sulfonamide derivatives 4-Chloro-N-[(4-methylphenyl) sulphonyl]-N-propyl ben-
zamide (1A), N-(2-hydroxyphenyl)-4-methyl benzene sulfonamide (1B) and 4-methyl-N-(2-nitrophenyl) ben-
zene sulfonamide (1C). The compounds were synthesised from starting material 4-methylbenzenesulfonyl chlo-
ride and their structure was studied through 1H-NMR and 13C-NMR spectra. Computational docking was per-
formed to estimate their binding energy against bacterial p-amino benzoic acid (PABA) receptor, the dihydrop-
teroate synthase (DHPS). The derivatives were tested in vitro for their antimicrobial activity against Gram+ and 
Gram- bacteria including E. coli, B. subtilis, B. licheniformis and B. linen. 1A was found active only against B. 
linen; 1B was effective against E. coli, B. subtilis and B. linen whereas 1C showed activity against E. coli, B. li-
cheniformis and B. linen. 1C showed maximum activity with minimum inhibitory concentration (MIC) of 50, 
100 and 150 µg/mL against E. coli, B. licheniformis and B. linen respectively. 1C exhibited maximum affinity to 
DHPS with binding free energy of -8.1 kcal/mol. It enriched in the top 0.5 % of a library of 7663 compounds, 
ranked in order of their binding affinity against DHPS. 1C was followed by 1B which showed a moderate to low 
level MIC of 100, 250 and 150 µg/mL against E. coli, B. subtilis and B. linen respectively, whereas 1A showed a 
moderate level MIC of 100 µg/mL but only against B. linen. These derivatives may thus serve as potential anti-
bacterial alternatives against resistant pathogens. 
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INTRODUCTION 
Antibiotic resistance is an inevitable evo-
lutionary phenomenon which renders antimi-
crobial products ineffective against infec-
tions. Antibiotic resistant microbial strains 
are posing substantial economic and health 
threats globally (Sengupta et al., 2013; 
Lushniak, 2014). Microbes have evolved 
various intrinsic mechanisms enabling them 
to develop antibiotic resistance specific to 
structural and functional features of 
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antibiotics (Sengupta et al., 2013). They ac-
quire resistance against active drugs through 
spontaneous mutations and horizontal gene 
transfer. Overuse of antibiotics gradually 
eliminates drug-sensitive strains leaving be-
hind drug resistant species to survive and re-
produce as a consequence of natural selec-
tion (Randall et al., 2013).  
Sulfonamides have long been in use as 
effective therapeutic agents against both 
Gram+ and Gram- bacterial strains associat-
ed with a range of infectious diseases (Nasr 
et al., 2016). These broad spectrum synthetic 
drug molecules compete with and inhibit the 
binding of p-amino benzoic acid (PABA) in 
binding site of dihydropteroate synthase 
(DHPS) enzyme thereby interfering with the 
vital bacterial dihydrofolic acid synthesis 
pathway (Seydel, 1968; Argyropoulou et al., 
2009). In bacteria, folic acid is an essential 
component required for DNA and RNA syn-
thesis. By disrupting folic acid synthesis 
pathway in bacterial cell, sulfonamides com-
promise the microbes’ ability to divide and 
reproduce. In addition to being antibacterial, 
sulfonamides and their derivatives are wide-
ly prescribed as insulin release inducers, an-
tiviral, antifungal, anti-cancer and anti-
inflammatory agents (Bano et al., 2011; 
Zoumpoulakis et al., 2012; Sławiński et al., 
2013).  
However, bacteria have developed re-
sistance against popular sulfonamide based 
drugs such as co-trimoxazol and sulfameth-
oxazole etc. Owing to the rise of resistance 
against sulfonamides in a number of bacteri-
al pathogens, the sulfonamides are hardly 
considered as first best option (Sławiński et 
al., 2013). Growing concern associated with 
antibiotic resistance has spurred further re-
search for more selective and efficacious an-
timicrobial solutions. To that effect, a rela-
tively direct and cost effective strategy for 
drug discovery is ligand based design, which 
involves designing new therapeutic mole-
cules based on structural and functional 
properties of already known drugs. The nov-
el derivatives improve basic structural and 
functional therapeutic attributes while decoy-
ing pathogen’s resistance mechanism.  
Here we report three novel sulfonamide 
derivatives, their mode of synthesis, physico-
chemical properties, structure, binding affini-
ties with DHPS, activity and Minimum In-
hibitory Concentration (MIC) against a set of 
Gram- and Gram+ bacteria. These novel de-
rivatives are listed below (Table 1).  
 
MATERIALS AND METHODS 
Structure of DHPS 
Structure of dihydropteroate synthase 
(DHPS) enzyme of Escherichia Coli,  de-
termined through X-Ray Crystallography, 
solved at 2.00Å resolution (PDB: 1AJ0) al-
ready bound with a sulfonamide ligand 
(C6H8N2O2S) was selected as target and re-
trieved  from RCSB’s PDB database  
(Achari et al., 1997). DHPS sulfonamide 
pocket is configured by H bond forming 
Ser219, Arg220, and Arg63 and aromatic 
Pro64, Phe190, Phe157 and Pro232 residues 
(Figure 1). 
 
 
Table 1: Sulfonamide derivatives synthesized in this study 
IUPAC Name Code Chemical Group 
4-chloro-N-[(4-methylphenyl)sulfonyl]-N-propyl benzamide 1A Sulfonamide 
N-(2-hydroxyphenyl)-4-methyl benzenesulfonamide 1B Sulfonamide 
4-methyl-N-(2-nitrophenyl) benzenesulfonamide 1C Sulfonamide 
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Figure 1: (a) Structure of Escherichia coli Dihydropteroate Synthase (DHPS), PDB: 1AJ0 (8). A sul-
fonamide molecule (C6 H8 N2 O2 S) molecule is bound inside the binding pocket. (b) Zoomed in bind-
ing pocket of DHPS shown in transparent surface, the sidechains of the residues configuring the bind-
ing pocket and imparting the polar and nonpolar interactions on sulfonamide molecule are labelled, 
three green dashed lines show hydrogen bonds with Arg 63, Ser219 and Arg 220.  
 
 
Structure and physical properties of Sul-
fonamide derivatives 
The structures of newly synthesized 
compounds were determined through NMR 
spectroscopy and mass spectrometry. The 
spectra were recorded on a Bruker DPX-400 
NMR spectrometer (Billerica, USA) (400 
MHz for 1H and 100 MHz for 13C-NMR), 
using CDCl3 as the solvent. The physical 
properties were also determined and charac-
terized by FT-IR  and Elemental analysis 
(CHNS).  
 
Synthesis of Sulfonamide derivatives 
In view of already known structure activ-
ity relationship of sulfonamide derivatives, 
three derivatives of sulfonamide were pre-
pared through substitution reactions with p-
toluene sulfonyl chloride as detailed below.  
Synthesis and structure of 4-Chloro-N-[(4-
methylphenyl) sulfonyl]- N-propyl ben-
zamide (1A) 
1A was obtained by reacting propan-1-
amine with 4-methylbenzenesulfonyl chlo-
ride at first followed by reaction with 3-
chlorobenzoyl chloride (Figure 2). Briefly, 
2.5 M solution of the propylamine (propan-
1-amine) was prepared in distilled water. The 
solution was added to 0.44 M p-toluene sul-
fonyl chloride (4-methylbenzenesulfonyl 
chloride). The mixture was stirred slowly for 
2-3 hours while maintaining pH during the 
reaction between 6-10 with 3 % Na2CO3. N-
propyl benzenesulfonamide thus formed was 
further reacted with 3-chlorobenzoyl chlo-
ride to obtain precipitates of 4-chloro-N-[(4-
methylphenyl) sulfonyl]-N-propyl ben-
zamide. The precipitates were then filtered 
and washed with cold water. TLC was per-
formed using the mixture of ethyl acetate 
and n-hexane (1:4) as mobile phase. 
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Crystalline form of compound 1A as off 
white powder (93 % yield) was obtained 
with following physical properties: molecu-
lar weight (351.85), molar refractivity 
(92.25±0.4 cm3), molar volume (275.6±3.0 
cm3), parachor (724.3±6.0 cm3), index of re-
fraction (1.58±0.02), surface tension 
(47.6±3.0 dyne/cm), density (1.276±0.06g/ 
cm3) and polarizability (36.57±0.5 10-24 
cm3). NMR data of compound 1A showed 
1H-NMR signals at  δ 7.821(d, J=2.12, 1H, 
H-3, H-5), 7.809 (d, J=2.2, 1H, H-3′, H-5′), 
7.735 (d, J=2.1, 1H, H-2, H-6), 7.351 (d, 
J=2.29, 1H, H-2′, H-6′), 4.207 (t, J=7, 2H, H-
8) and 13C-NMR found signals at δ/ppm: 
128.8, 128.8, 135.7, 165.7, 144.3, 56.9, 21.3, 
129.7, 129.7, 45.5, 127.5, 127.5, 135.1, 
128.9, 128.9, 133.7, 11.1. Elemental analysis 
of compound 1A found C (58.06 %), H 
(5.16 %), N (3.985), O (13.64 %), S (9.11 %) 
and Cl (10.08 %). 
Synthesis and structure of N-(2-
hydroxyphenyl)-4-methyl benzenesulfona-
mide (1B) 
1B was synthesized by reacting 2-
aminophenol with 4-methylbenzenesulfonyl 
chloride, TLC was performed and the precip-
itates were filtered and washed with distilled 
cold water in a procedure similar to de-
scribed earlier (Figure 3). Physical properties 
of white crystalline solid 1B (yield: 91 %) 
were: molecular weight (263.12), melting 
point (76 °C), molar refractivity (70.08±0.4 
cm3), molar volume (193.2±3.0 cm3), para-
chor (538.8±6.0 cm3), index of refraction 
(1.64±0.02), surface tension (60.4±3.0 
dyne/cm), density (1.36±0.06 g/cm3) and po-
larizability (27.78±0.5 10-24 cm3); 1H-NMR 
signals at δ 7.86 (d, J=8.4, 1H, H-2, H-6), 
7.57 (t, J=, 1H, H-3, H-5), 7.55 (dd, J=1.8, 
7.3, 1H, H-4), 7.46 (d, J=7.5, 1H, H-2′, H-
6′), 7.19 (d, J=7.5, 1H, H-3′, H-5′), 2.36 (s, 
J); 13C-NMR (CDCl3, 100 MHz)  signals at 
δ/ppm: 136.0, 113.7, 117.3, 127.5, 127.5, 
144.3, 147.2, 129.7, 129.7, 21.3, 125.3, 
131.2, 127.7. Elemental analysis of com-
pound 1B showed C (59.30 %), H (4.98 %), 
N (5.32 %), O (18.23 %) and S (12.18 %). 
Figure 2: (a) Reaction of 
propan-1-amine with 4-
methylbenzenesulfonyl 
chloride to produce 4-
methyl-N-propylbenzene-
sulfonamide, (b) 4-methyl-
N-propylbenzenesulfona-
mide was further reacted 
with 3-chlorobenzoyl chlo-
ride to obtain 4-chloro-N-
[(4-methylphenyl) sulfo-
nyl]-N-propylbenzamide.  
EXCLI Journal 2018;17:169-180 – ISSN 1611-2156 
Received: October 17, 2017, accepted: January 29, 2017, published: February 01, 2018 
 
 
173 
 
Figure 3: Reaction of 2-aminophenol with 4-methylbenzenesulfonyl chloride producing N-(2-
hydroxyphenyl)-4-methyl benzenesulfonamide (1B). 
 
Synthesis and structure of 4-methyl-N-(2-
nitrophenyl) benzenesulfonamide (1C) 
In a procedure similar to that described 
earlier, 1C was synthesized by reacting 2-
nitroaniline with 4-methylbenzenesulfonyl 
chloride (Figure 4), separated by TLC, crys-
talized, washed and dried as  off-white crys-
talline solid (yield 93 %). Its physical prop-
erties were determined as: molecular weight 
(293.31), molar refractivity (74.58±0.4 cm3), 
molar volume (206.6±3.0 cm3), parachor 
(580.7±6.0 cm3), index of refraction 
(1.64±0.02), surface tension (62.3±3.0 
dyne/cm), density (1.41±0.06 g/cm3), polar-
izability (29.56±0.5 10-24 cm3) and melting 
point (167 °C); 1H-NMR showed signals at  
δ 7.821 (d, J=2.12, 1H, H-3, H-5), 7.80 (d, 
J=2.2, 1H, H-3′, H-5′), 7.735 (d, J=2.1, 1H, 
H-2, H-6), 7.351 (d, J=2.29, 1H, H-2′, H-6′), 
4.207 (t, J=7, 2H, H-8); 13C-NMR δ/ppm 
was: 117.3, 144.3, 127.7, 129.7, 129.7, 
127.5, 127.5, 140.5, 117.3, 140.5, 127.7, 
136.0, 21.3. Elemental analysis (CNHS) in-
dicated C (53.42 %), H (4.14 %), N 
(9.58 %), O (21.89 %) and S (10.97 %), in 
the compound. 
 
In silico screening of sulfonamide  
derivatives seeded compound library 
Before undertaking activity assays, we 
decided to screen a representative set of 
compounds against DHPS to see their rela-
tive binding affinity with the target.  
Development of compound library  
A diverse library of 6990 selected com-
pounds was built from a number of open 
source compound libraries including com-
pounds comparable in size, structure, physi-
cal and chemical properties to our sulfona-
mide derivatives. Structure files for sulfona-
mides 1A, 1B & 1C were written in .mol2 
format and were subjected to Multiconf-
Dock software (Sauton et al., 2008) to gen-
erate different conformers of the synthesized 
sulfonamide derivatives. The conformers  
 
 
 
Figure 4: 2-nitroaniline was reacting with 4-methylbenzenesulfonyl chloride to synthesize 4-methyl-N-
(2- nitrophenyl) benzenesulfonamide, 1C. 
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showed a maximum Root Mean Square De-
viation (RMSD) of 2Å and free energy devi-
ation of 10 KJ/mol from the parent structures. 
Thus 672 conformers of 1A, 1B & 1C were 
generated. These conformers along with 
DHPS bound sulfonamide ligand (4-amino-
benzenesulfonamide, C6 H8 N2 O2 S) as in 
1AJ0 PDB file were also seeded in the com-
pound library of 6990 compounds to make 
up a total of 7663 compounds in .mol2 for-
mat.  
ADMET of compound library 
Absorption, Distribution, Metabolism, 
Excretion and Toxicity (ADMET) values of 
compounds were estimated based on struc-
tural characteristics or structural alerts.  The 
compounds were rated in three categories 
which included: 1) those derivatives that 
were present in accepted range which ful-
filled the physiochemical filter, 2) the com-
pounds that lied in intermediate range i.e. 
showing low or very few structural alerts and 
3) the compounds present in the rejected list 
showing high structural alerts. The last, be-
ing not suitable drug candidates, were delet-
ed. Drug likeliness of the compounds was 
measured on the basis of Lipinski’s rule of 
five (RO5).  
Molecular docking against DHPS 
Molecular docking studies against 1AJ0 
were carried out in Molecular Operating En-
vironment (MOE) software (Chemical 
Computing Group ULC, 2013). Being more 
accurate and faster, MOE is widely used to 
undertake in silico ligand screening and to 
predict binding affinities between small mol-
ecules and receptor protein targets. Screened 
library of 7663 compounds including 672 
conformers of 1A, 1B and 1C were opti-
mized in MOE. Ligand optimization includ-
ed addition of partial charges through Proto-
nate3D tools and subsequent energy minimi-
zation of these hits by applying MMFF94X 
force field. Afterwards optimized ligands 
were added to the MOE ligand database in-
dividually for docking purpose. Similarly 
PDB file of E. coli DHPS (1AJ0) was also 
prepared for docking by addition of non-
polar hydrogen, removal of water molecules 
and energy minimization. Once the receptor 
protein was ready, site finder tool was ap-
plied to find active site in 1AJ0 structure and 
an electrostatic surface map was created 
around it to define the docking site. Later 
sulfonamide derivatives containing ligand 
database was docked within the defined 
docking site of 1AJ0. This tool uses triangu-
lar matcher algorithm as a default ligand 
placement methods to find 1000 best con-
formations of  subject ligands within the 
binding pockets of the target protein 
(Lengauer and Rarey, 1996). These 1000 
poses were rescored through London dG 
scoring function to select top 10 confor-
mations per molecule. For each confor-
mation, final binding energy, S-score and 
RMSD values were calculated by General-
ized Born Solvation Model by keeping the 
active pocket residues rigid. To validate 
docking protocol of MOE, a test run was ac-
complished using the co-crystallized sulfon-
amide ligand bound in 1AJ0 as control. 
 
Procedure for determining antibacterial  
activity 
Both Gram-, Escherica coli (E. coli), and 
Gram+ bacteria, Bacillus subtilis (B. sub-
tilis), Bacillus licheniformis (B. licheniform-
is) and Brevibacterium linens (B. linens), 
were used to determine the activity. Inocula 
of the microbes were prepared in sterilized 
LB media following standard set of proto-
cols. Sterilized petri dishes of agar medium 
were prepared and sterilized. The activity 
was measured by well diffusion and disc dif-
fusion method as detailed below.  
Well diffusion method 
100 µl of inoculum of each of the mi-
crobes mentioned above was spread over the 
media layer of the petri dishes in triplicate 
with a sterile cotton swab, and were put to 
incubate for an hour to dry. Wells 7 mm in 
diameter, 20 mm apart, were casted by a 
sterilized pipette cut near the tip. Solution of 
each of the compounds 1A, 1B and 1C were 
prepared at a concentration of 300 µg/mL. A 
300 µg/mL solution of sulfamethoxazole and 
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nutrient broth were also prepared to serve as 
positive and negative control respectively. 
100 µl of each of the solutions were added in 
wells of aforementioned culture plated petri 
dishes for each of the four microbe cultures 
in triplicate and incubated for 24 hours at 
36±1 °C (Table 2). 
Disc diffusion method 
The well diffusion experiment was also 
repeated in disc diffusion assay. In this assay 
instead of wells 7 mm wide Whatman filter 
paper discs were used. The discs were 
soaked with 2 mL of each sample solution, 
ensuring the final dry amount of the 1A, 1B 
and 1C to remain same as much as poured in 
wells in solution form; the discs were left at 
room temperature until complete evapora-
tion. Discs were then placed over the surface 
of agar and results were recorded. 
Procedure for determining MIC 
Minimum inhibitory concentration (MIC) 
was estimated through micro-dilution meth-
od. The nutrient broth solution was prepared 
and incubated for 48 hours. 100 mg of each 
of the sample compounds was solubilized. 
Dilutions of 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 
mg/mL were prepared. 0.7 mL of media (nu-
trient broth) and 100 µl each of the afore-
mentioned diluted solutions were added in 
different test tubes along with 200 µl each of 
the inoculum culture. Thus the final concen-
trations of 50, 100, 150, 200, 250 and 
300 µg/ mL were achieved in each of the 
tubes. The conditions were kept same for 
positive and negative control. The tubes 
were incubated for eighteen hours. Using 
this methodology, lowest concentration in 
µg/mL units of each derivative showing in-
hibition in growth was estimated. 
RESULTS AND DISCUSSION 
Structural and physicochemical characteri-
zation of Sulfonamide derivatives 
The structures of newly synthesized 
compounds were determined through spec-
troscopic data of IR, 1H NMR, 13C NMR and 
mass spectra; the physical properties were 
also determined and characterized by FT-IR 
and elemental analysis (CHNS) as given in 
Materials and Methods. Drug likeliness of 
the derivatives was evaluated on the basis of 
Lipinski’s RO5 in which is regarded as a rule 
of thumb to distinguish between drug and 
non-drug like compounds. It predicts the 
probability of success of prospective drug 
likeliness for the subject compound on the 
basis of its molecular mass (≤ 500 Dalton), 
hydrogen bond donors (≤ 5), hydrogen bond 
acceptors (≤10), lipophilicity (expressed as 
LogP ≤ 5) and molar refractivity (between 1-
40). In order to qualify as a prospective drug, 
a compound should meet at least two or 
more aforementioned thresholds. All of our 
sulfonamide derivatives 1A, 1B and 1C qual-
ified the ADMET and Lipinski’s rule (RO5) 
criteria for their drug likeliness.  
 
Activity of 1A, 1B and 1C against microbes 
Antimicrobial activity of the sulfonamide 
derivatives 1A, 1B and 1C against a set of 
Gram+ and Gram- bacteria including E. coli, 
B. subtilis, B. licheniformis and B. linens was 
also determined using sulfamethoxazole as a 
reference.  1A was found active against B. 
linens, whereas 1B was active against E. 
coli, B. subtilis and B. linens. 1C was effec-
tive against E. coli, B. licheniformis and B. 
linens (Table 2). 
 
Table 2: Activity of Sulfonamide derivatives 1A, 1B and 1C against bacterial pathogens E. coli, B. sub-
tilis, B. licheniformis and B. linen 
Compounds E. coli B. subtilis B. licheniformis B. linens 
1A - - - Active 
1B Active Active - Active 
1C Active --- Active Active 
Nutrient Broth (Negative Control) - - - --- 
Sulfamethoxazole (Positive Control) Active Active Active Active 
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1A showed moderate level of activity 
with Minimum Inhibitory Concentration 
(MIC) of 100 µg/mL but only against B. lin-
ens. 1B was active against 3 of the 4 bacteri-
al species used in this study, namely E. coli, 
B. subtilis, and B. linens. However, its MIC 
values of 100, 250 and 150 µg/mL indicated 
a range of moderate to low level of activity. 
On the other hand, 1C showed maximum ac-
tivity with MIC of 50, 100 and 150 µg/mL 
against E. coli, B. licheniformis and B. lin-
ens, respectively (Table 3). 
 
Molecular docking 
The newly synthesized sulfonamide de-
rivatives showed promising activity against 
Gram+ and Gram- bacteria particularly 
against E. coli, the Gram- bacterium, with 
the exception of 1A, which was found effec-
tive only against B. linens. Most effective of 
these derivatives was 1C with best activity 
(MIC 50 µg/ml) against E. coli. This is im-
portant because E. coli is known to develop 
resistance rapidly against antibacterial drugs. 
Addition of 1C in the list of drugs effective 
against this bacterium is quite significant. 
Against B. subtilis however, 1C showed no 
activity.  
Prior to the activity assays, computation-
al studies involving molecular docking were 
undertaken to investigate structural and func-
tional basis of antibacterial activity of our 
newly synthesized sulfonamide derivatives 
by estimating in silico binding affinities and 
binding conformations. Firstly, the native 
sulfonamide ligand was docked against 
DHPS structure at MOE. The ligand occu-
pied the DHPS binding pocket in exactly 
same conformation showing 0Å RMSD to 
the co-crystallized structure (1AJ0). Ligand 
conformations were same with focused 
docking, (when receptor binding pocket di-
mensions and coordinates were defined 
through 3D grid) and with blind docking 
(when binding pocket was not defined and 
the whole receptor structure was targeted for 
docking). Thus, DHPS binding pocket was 
found perfectly selective for sulfonamides.  
In the second instance, an exhaustive 
docking protocol was followed, which in-
volved both blind and focused docking of 
our selected library of 7663 compounds 
seeded with 672 conformers of 1A, 1B and 
1C and also the native sulfonamide ligand 
bound with DHPS. The docked compounds 
were later ranked on the basis of their bind-
ing affinity. Interestingly, derivative 1C 
ranked in top 40 compounds both in focused 
and blind docking out of a library of com-
pounds which included popular sulfonamide 
drugs such as sulfacetamide, sulfadiazine, 
sulfisoxazole, sulfisomidine, sulfaisodimi-
dine, sulfadoxine and sulfamethoxazole with 
a binding affinity of -8.1 kcal/mol (Figure 5). 
Figure 6 shows the binding pose of 1C in 
the pocket of DHPS. 1C exhibited strong hy-
drogen bonds with binding pocket residues 
Arg63 and Ser219 involving nucleophilic 
oxygen of the sulfonyl group and nitrogen of 
the amino group. Whereas, strong hydropho-
bic interaction was also exhibited by other 
residues of the binding pocket which include 
Ile20, Pro64, Ile117, Phe 190, Lys221, 
Ser219, Gly227 and His257.   
 
 
 
Table 3: Minimum Inhibitory Concentration (MIC) of 1A, 1B, and 1C against various bacterial strains  
Compounds 
Minimum Inhibitory Concentration (MIC) µg/ml 
Bacterial strains 
E. coli B. subtilis B. licheniformis B. linens 
1A -- -- -- 100 
1B 100 250 -- 150 
1C 50 -- 100 150 
Sulfamethazole (Positive Control) 50 50 50 50 
Nutrient Broth (Negative Control) -- -- -- -- 
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Figure 5: Ranges of binding energy exhibited by the compounds in the library. Each histogram repre-
sents fraction of the compound library in percent (%) exhibiting the corresponding range of binding 
energy at the x-axis; the values are shown in positive. 1C with a binding energy of 8.1 kcal/mol was 
found in the most favorable range (8.1-8.5 kcal/mol) enriching in the top 0.57 % of the library. 
 
 
 
Figure 6: 1C bound in DHPS binding pocket. A: DHPS residues exhibiting multiple interactions with 
1C, inhibiting its PABA binding pocket. Green dotted lines represent hydrogen bonds between Arg63 
and oxygen of sulfonyl group, and between Ser219 and -NH group of 1C. B: 2D representation of 
DHPS in complex with 1C. Residues are represented in three letter code with their position. Arrows in 
green dotted lines represent hydrogen bonds with donor at the base and acceptor at the arrow head. 
Polar and hydrophobic residues are shown with purple and green interiors respectively; the basic resi-
dues are shown in blue rings. Differences in solvent accessible surface area for 1C atoms and DHPS 
residues are plotted as blue smudge and turquoise halo, respectively. 
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1B also exhibited appreciable interaction 
to the binding pocket of DHPS. Strong hy-
drogen bond between Arg255 and the oxy-
gen of sulfonyl group was observed. In addi-
tion to this, residue Arg63 exhibited arene-
cation interaction with the methyl benzene-
sulfonamide group of 1B (Figure 7). Binding 
score of 1B with binding pocket of DHPS 
was observed to be -5.4 kcal/mol. Other 
binding pocket residues Ile20, Asn22, Glu60, 
Ser61, Thr62, Asp96, Phe190, Ser219, 
Lys221, Asp220, Ser222 and Arg235 were 
also found interacting with 1B. 
1A exhibited arene-hydrogen bond inter-
action with binding pocket residue, His257, 
while its binding energy was found to be -4.2 
kcal/mol. His257 being a basic residue usu-
ally participates in hydrogen bonding by ac-
cepting protons. Other binding pocket resi-
dues exhibiting hydrophobic interactions 
were Ile20, Asn22, Ser27, His43, Arg63, 
Arg220 and Asp258 (Figure 8). 
This study reports three novel sulfona-
mide derivatives which showed activity 
against both Gram+ and Gram- bacterial 
pathogens. 1A showed moderate level activi-
ty against B. linens. 1B was active against E. 
coli, B. subtilis and B. linens showing mod-
erate to low level activity. 1C was the most 
active sulfonamide derivative with a high 
level activity against E. coli and moderate 
level activity against B. licheniformis and B. 
linens (Tables 1&2). The derivatives have 
demonstrated appreciable structural and 
functional properties to inhibit the PABA 
binding pocket of bacterial DHPS with opti-
mum values of binding energy (Figures 6-8). 
Of a particular importance is 1C which en-
riched in top 0.57 % of the compound library 
ranked in order of the binding energy when 
docked against DHPS (Figure 5). Surprising-
ly, 1C did not show any activity against B. 
subtilis.  
 
 
Figure 7: 1B bound in DHPS in binding pocket. A: DHPS residues exhibiting multiple interactions with 
1B. Green dotted lines represent hydrogen bond between Arg255 and oxygen of sulfonyl group of 1B 
and arene-cation interaction between Arg63 and aromatic ring of methyl benzenesulfonamide group. 
B: 2D representation of DHPS in complex with 1B. Residues are represented in three letter code with 
their position. Arrows in green dotted lines represent hydrogen bonds with donor at the base and ac-
ceptor at the arrow head. Polar and hydrophobic residues are shown with purple and green interiors 
respectively; the acidic and basic residues are differentiated by red and blue rings respectively. Differ-
ences in solvent accessible surface area for 1B atoms and DHPS residues are plotted as blue smudge 
and turquoise halo respectively. 
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Figure 8: 1A bound in binding pocket of DHPS. A: Green dotted lines represent arene-hydrogen bond 
between His257 and 1A. B: 2D representation of DHPS in complex with 1A.  Residues are represent-
ed in three letter code with their position. Arrows in green dotted lines represent hydrogen bonds with 
donor at the base and acceptor at the arrow head. Polar and hydrophobic residues are shown with 
purple and green interiors respectively; the acidic and basic residues are differentiated by red and blue 
rings respectively. Differences in solvent accessible surface area for 1A atoms and DHPS residues 
are represented as blue smudge and turquoise halo respectively. 
 
 
Owing to their prolonged usage, bacteria 
have developed resistance against reputed 
sulfonamide drugs. Thus their capacity to in-
hibit microbial pathways has been gradually 
compromised (Sköld, 2000). Ligand based 
strategies have been widely employed to dis-
cover active sulfonamide derivatives. A 
number of research studies have sought to 
develop novel sulfonamide derivatives 
through structure aided optimization of al-
ready known sulfonamide scaffolds to 
achieve maximum biological activity and 
minimum microbial resistance (Ezabadi et 
al., 2008; Kamel et al., 2010; Zoumpoulakis 
et al., 2012; Mondal et al., 2015). Thus new 
sulfonamide derivatives may inhibit the tar-
get enzymes as well as decoy the bacterial 
resistance mechanisms. Designed through 
ligand based approach, three novel sulfona-
mide derivatives (1A, 1B and 1C) with sub-
stantial drug potential are presented for fur-
ther in vivo and clinical verification.  
 
CONCLUSION 
This study describes synthesis, structure 
and physico-chemical properties of three 
novel sulfonamide derivatives with their 
structural and functional affinities and their 
MIC values against a set for Gram+ and 
Gram- bacteria. To the best of our 
knowledge, these derivatives, their synthesis 
and physico-chemical properties along with 
computational docking investigations and in 
vitro antimicrobial studies against the subject 
bacterial species have not been reported be-
fore. The reported derivatives exhibited sig-
nificant antimicrobial properties against bac-
teria. 4-methyl-N-(2-nitrophenyl) benzene-
sulfonamide (1C) was found highly active 
against E. coli along with B. licheniformis 
and B. linens as indicated by its high MIC 
and binding energy values. This was fol-
lowed by N-(2-hydroxyphenyl)-4-methyl 
benzenesulfonamide (1B) which showed 
moderate to low activity against E. coli, B. 
subtilis and B. linens; whereas 4-chloro-N-
[(4-methylphenyl) sulfonyl]- N-propyl ben-
zamide (1A) was found moderately active 
against B. linens. Thus 1C was found most 
active derivative and it may serve as an ef-
fective drug particularly against E. coli relat-
ed pathogenesis. 
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